A randomized, double-blind, placebo-controlled study of tumor necrosis factor-α blockade in severe persistent asthma

…, R Schlenker-Herceg, KH Lo, R Watt… - American journal of …, 2009 - atsjournals.org
Rationale: The treatment effect of golimumab, a human monoclonal antibody against tumor
necrosis factor (TNF)-α, in severe persistent asthma is unknown. Objectives: To assess the …

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

…, R Prabhu, JF Donohue, R Watt… - American journal of …, 2007 - atsjournals.org
Rationale: Chronic obstructive pulmonary disease (COPD) is a progressive, smoking-related,
inflammatory lung disease in which tumor necrosis factor-α is overexpressed and has …

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

…, G Schwab, E Wickstrom, SL Loke, DH Pluznik, R Watt… - Nature, 1987 - nature.com
Initiation of T-lymphocyte proliferation by mitogen or antigen involves a cascade of gene
activation events. Thus, by the time mitogen-activated T cells have reached the G 1 /S interface, …

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

…, P Agarwal, C Brodmerkel, R Watt… - European …, 2014 - Eur Respiratory Soc
Sarcoidosis is characterised by non-caseating granulomas that secrete pro-inflammatory
cytokines, including interleukin (IL)-12, IL-23, and tumour necrosis factor (TNF)-α. Ustekinumab …

Microinjected c-myc as a Competence Factor

L Kaczmarek, JK Hyland, R Watt, M Rosenberg… - Science, 1985 - science.org
While a number of oncogenes are expressed in a cell cycle-dependent manner, their role in
the control of cell proliferation can only be established by a direct functional assay. The c-…

Differential Expression of the Translocated and the Untranslocated c-myc Oncogene in Burkitt Lymphoma

A Ar-Rushdi, K Nishikura, J Erikson, R Watt, G Rovera… - Science, 1983 - science.org
Burkitt lymphoma cells carrying either a rearranged or unrearranged c-myc oncogene were
examined with the use of probes from the 5′ exon and for the second and third exon of the …

Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas

LW Stanton, R Watt, KB Marcu - Nature, 1983 - nature.com
Comparative nucleotide sequence analysis of a rearranged c-myc gene in a murine
plasmacytoma and c-myc cDNA from normal spleen reveals that chromosomal translocation in the …

Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia

…, LW Stanton, J Erikson, R Watt… - Proceedings of the …, 1983 - National Acad Sciences
NIARD (non-immunoglobulin-associated rearranging DNA) is located on mouse chromosome
15 at the break point of a commonly observed translocation event involving chromosomes …

Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.

…, A ar-Rushdi, J Erikson, R Watt… - Proceedings of the …, 1983 - National Acad Sciences
We have investigated whether the translocated and the untranslocated human c-myc oncogenes
of Burkitt lymphoma cells are equally or differentially expressed in host mouse B cells. …

Expression and Characterization of the Human c-myc DNA-Binding Protein

RA Watt, AR Shatzman… - Molecular and cellular …, 1985 - Taylor & Francis
In an effort to study in detail the nature of the protein product of the human protooncogene c-myc,
we have expressed the gene at high levels in Escherichia coli. The c-myc coding …